Back to Markets
EDEditas Medicine Inc

Editas Medicine Inc

EDITNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.46

+0.0300 (+0.87%)

As of 05/29/26 EDT · USD

Compare
Low: $1.66Current: $3.46High: $4.54

Key Statistics

Open

$3.41

Day High

$3.50

Day Low

$3.24

Prev. Close

$3.43

VolumeShares traded today.

3.45M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$580.55M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.83

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$4.54

52W LowLowest price over the past 52 weeks.

$1.66

50D MAAverage closing price over the last 50 trading days.

$2.89

200D MAAverage closing price over the last 200 trading days.

$2.67

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+29.6%

1M

+22.7%

6M

+44.8%

YTD

+68.8%

1Y

+95.5%

About

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

www.editasmedicine.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade EDIT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.